These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23797970)

  • 1. Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy.
    Al-Mamgani A; van Rooij PH; Mehilal R; Verduijn GM; Tans L; Kwa SL
    Eur Arch Otorhinolaryngol; 2014 Jan; 271(1):125-32. PubMed ID: 23797970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for T1-2N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients.
    Al-Mamgani A; van Rooij PH; Woutersen DP; Mehilal R; Tans L; Monserez D; Baatenburg de Jong RJ
    Clin Otolaryngol; 2013 Aug; 38(4):306-12. PubMed ID: 23731781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Vocal Cord Irradiation: Image Guided Intensity Modulated Hypofractionated Radiation Therapy for T1a Glottic Cancer: Early Clinical Results.
    Al-Mamgani A; Kwa SL; Tans L; Moring M; Fransen D; Mehilal R; Verduijn GM; Baatenburg de Jong RJ; Heijmen BJ; Levendag PC
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):337-43. PubMed ID: 26264629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis.
    Greulich MT; Parker NP; Lee P; Merati AL; Misono S
    Otolaryngol Head Neck Surg; 2015 May; 152(5):811-9. PubMed ID: 25837666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
    Khan MK; Koyfman SA; Hunter GK; Reddy CA; Saxton JP
    Radiat Oncol; 2012 Nov; 7():193. PubMed ID: 23164282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
    Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.
    Mucha-Małecka A; Chrostowska A; Urbanek K; Małecki K
    Strahlenther Onkol; 2019 Sep; 195(9):792-804. PubMed ID: 31214734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of T1b glottic SCC: laser vs. radiation--a Canadian multicenter study.
    Taylor SM; Kerr P; Fung K; Aneeshkumar MK; Wilke D; Jiang Y; Scott J; Phillips J; Hart RD; Trites JR; Rigby MH
    J Otolaryngol Head Neck Surg; 2013 Mar; 42(1):22. PubMed ID: 23672802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health status and voice outcome after treatment for T1a glottic carcinoma.
    Peeters AJ; van Gogh CD; Goor KM; Verdonck-de Leeuw IM; Langendijk JA; Mahieu HF
    Eur Arch Otorhinolaryngol; 2004 Nov; 261(10):534-40. PubMed ID: 14714128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
    Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
    Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical options in radiotherapy-failed early glottic cancer.
    Santoro R; Meccariello G; Mannelli G; Bini B; Paiar F; Gallo O
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):777-85. PubMed ID: 23760534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and voice assessment in patients with early-stage glottic cancer.
    Arias F; Arraras JI; Asin G; Uzcanga MI; Maraví E; Chicata V; Eito C; Zarandona U; Mora I; Vila M; Domínguez MA
    Head Neck; 2015 Mar; 37(3):340-6. PubMed ID: 24415515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy.
    Oie Y; Itoh Y; Kawamura M; Takase Y; Murao T; Ishihara S; Nomoto Y; Hirasawa N; Asano A; Yamakawa K; Ito J; Kinoshita F; Naganawa S
    Nagoya J Med Sci; 2021 Nov; 83(4):811-825. PubMed ID: 34916724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer.
    Loughran S; Calder N; MacGregor FB; Carding P; MacKenzie K
    Clin Otolaryngol; 2005 Feb; 30(1):42-7. PubMed ID: 15748189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated radiotherapy for T1 to T2 glottic cancer.
    Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
    Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice.
    Remmelts AJ; Hoebers FJ; Klop WM; Balm AJ; Hamming-Vrieze O; van den Brekel MW
    Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):2079-87. PubMed ID: 23568036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.